Search Count: 60
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: PROTEIN FIBRIL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) E166V Mutant In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F And E166V) In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY, VIB, GOL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (T21I And E166V) In Complex With Inhibitor Enstrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 7YY |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) F140L Mutant In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (T21I And E166V) In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) A193P Mutant In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) L167F Mutant In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Double Mutant (L50F And E166V) In Complex With Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI |
 |
The Crystal Structure Of Sars-Cov-2 3C-Like Protease Double Mutant (L50F And E166V) In Complex With A Traditional Chinese Medicine Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: ODN |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Mutant (T21I) In Complex With Protease Inhibitor Nirmatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2023-10-11 Classification: VIRAL PROTEIN Ligands: 4WI, LQZ |